Hepion Pharmaceuticals, Inc. (HEPA) Balance Sheet

OTC Pink: HEPAAssets, liabilities, debt and equity over 10 years.

HEPA balance sheet, 2025

December 31, 2025 · U.S. dollars

$3.1M assets = $402,405 liabilities + $2.7M equity

What it owns$3.1MCash & ST investments: $1.8M (59.5%)Cash & ST investments$1.8M · 60%Other current: $1.2M (40.5%)Other current$1.2M · 40%=How it is financed$3.1MCurrent liabilities: $299,383 (9.8%)$299,383Other LT liabilities: $103,022 (3.4%)Shareholders’ equity: $2.7M (86.9%)Shareholders’ equity$2.7M · 87%

Both columns are drawn to the same scale: what HEPA owns equals what it owes plus shareholders’ equity. Hover a block for its value.

HEPA financial health

Debt / equity0.02
Low leverage · $0.02 of debt for each $1 of equity
Equity / assets86.9%
Equity-funded · of assets funded by shareholders
Cash / debt3,381.2%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

HEPA balance sheet trends, 2016–2025

Hepion Pharmaceuticals, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$13.1M2016$3.1M2025−14.9%/yr
Total liabilities$11.8M2016$402,4052025−31.3%/yr
Shareholders’ equity$1.3M2016$2.7M2025+8.2%/yr
Cash & short-term investments$7.4M2016$1.8M2025−14.4%/yr
Total debt$10,4102016$54,0662025+20.1%/yr
Net cash (debt)$7.4M2016$1.8M2025−$5.6M
Working capital$2.8M2016$2.8M2025−$40,869
Debt / equity0.0120160.022025+0.01

Change is the average annual growth (CAGR) or the difference between the first and latest year.

HEPA assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

HEPA liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

HEPA debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

HEPA balance sheet

Hepion Pharmaceuticals, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$1.8M$406,408$14.8M$51.2M$91.3M$40.7M$13.9M$2.8M$6.0M$7.4M
Cash & equivalents$1.8M$406,408$14.8M$51.2M$91.3M$40.7M$13.9M$2.8M$6.0M$7.4M
Receivables$0$0$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0
Other current assets$1.2M$1.2M$2.7M$5.3M$6.1M$1.9M$465,693$135,591$108,075$491,045
Total current assets$3.1M$1.6M$17.5M$56.5M$97.5M$42.6M$14.4M$3.0M$6.1M$7.9M
Property, plant & equipment (net)$0−$1$242,365$3.3M$456,461$664,932$855,079$32,434$56,595$80,848
Goodwill & intangible assets$0$0$0$3.2M$5.1M$5.1M$5.1M$5.1M$5.1M$5.1M
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$0$1$364,192$0$582,847$285,098$306,880$127,794$73,289$69,955
Total assets$3.1M$1.6M$18.1M$60.2M$103.6M$48.6M$20.6M$8.2M$11.3M$13.1M
Liabilities
Accounts payable$167,810$220,202$2.3M$2.7M$2.4M$3.7M$491,557$748,428$1.6M$4.3M
Short-term debt$54,066$2.9M$115,916$53,614$266,650$279,826$266,696$1.4M—$10,410
Deferred revenue——$2.4M$4.8M$2.5M—————
Total current liabilities$299,383$3.1M$5.3M$7.9M$8.2M$4.7M$1.6M$2.8M$2.6M$5.1M
Long-term debt$0$0$0$0$0$176,585$0$0$0$0
Lease obligations—$0$209,020$53,614$316,992$575,581$807,447——$0
Other long-term liabilities$103,022$333,189$5.5M$2.5M$2.4M$3.3M$3.4M$3.4M$4.9M$6.7M
Total liabilities$402,405$3.5M$10.8M$10.4M$10.6M$8.1M$5.0M$6.2M$7.5M$11.8M
Shareholders' equity
Common stock & paid-in capital$1,162$14$482$381$7,623$3,203$375$25$7,828$3,224
Retained earnings (deficit)−$246.1M−$237.8M−$224.6M−$175.7M−$133.5M−$104.1M−$83.8M−$76.5M−$67.0M−$44.6M
Accumulated other comprehensive income$8,345$8,345−$78,779−$90,168$0$0——$0—
Total shareholders' equity$2.7M−$1.9M$7.3M$49.9M$93.0M$40.5M$15.6M$2.0M$3.7M$1.3M
Key figures
Total debt$54,066$2.9M$209,020$53,614$316,992$752,166$807,447$1.4M—$10,410
Net cash (debt)$1.8M−$2.5M$14.6M$51.1M$91.0M$40.0M$13.1M$1.4M—$7.4M
Working capital$2.8M−$1.5M$12.2M$48.6M$89.2M$38.0M$12.8M$118,171$3.5M$2.8M
Tangible book value$2.7M−$1.9M$7.3M$46.7M$87.9M$35.5M$10.6M−$3.1M−$1.4M−$3.7M
Current ratio10.250.513.317.1611.889.158.941.042.331.55
Quick ratio6.110.132.806.4911.138.748.650.992.291.46
Debt / equity0.02—0.030.000.000.020.050.73—0.01
Equity / assets86.9%−115.5%40.2%82.8%89.8%83.3%75.8%24.1%32.9%10.1%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 12, 2026); data from EODHD.

HEPA financial position

At the end of fiscal 2025 (December 31, 2025), Hepion Pharmaceuticals had total assets of $3.1 million (up 90.2% from a year earlier), total liabilities of $0.4 million and shareholders' equity of $2.7 million. It held $1.8 million in cash and short-term investments against $0.1 million of debt, a net cash position of $1.8 million. Its current ratio was 10.25. In the latest quarter (ended June 30, 2026) total assets were $1.9 million and equity $1.3 million.

Related: HEPA income statement, HEPA cash flow statement, HEPA key metrics. See the HEPA stock overview for the latest quote and news.

HEPA balance sheet FAQ

What are Hepion Pharmaceuticals's total assets?

Hepion Pharmaceuticals reported total assets of $3.1 million at the end of fiscal 2025 (December 31, 2025), compared with $1.6 million a year earlier.

How much debt does Hepion Pharmaceuticals have?

Hepion Pharmaceuticals had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.02.

How much cash does Hepion Pharmaceuticals have?

Hepion Pharmaceuticals held $1.8 million in cash and short-term investments at the end of fiscal 2025; with $0.1 million of debt that is net cash of $1.8 million.

What is Hepion Pharmaceuticals's book value?

Hepion Pharmaceuticals's shareholders' equity (book value) was $2.7 million at the end of fiscal 2025.

What is Hepion Pharmaceuticals's current ratio?

Hepion Pharmaceuticals had current assets of $3.1 million and current liabilities of $0.3 million, a current ratio of 10.25 (it can cover its short-term obligations).

Biotechnology: balance sheet